ResMed ROA 2010-2025 | RMD

Current and historical return on assets (ROA) values for ResMed (RMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
ResMed ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $1.31B $7.57B 18.23%
2024-12-31 $1.25B $7.14B 17.80%
2024-09-30 $1.11B $7.22B 15.99%
2024-06-30 $1.02B $6.87B 14.93%
2024-03-31 $0.96B $6.82B 14.08%
2023-12-31 $0.89B $6.91B 13.15%
2023-09-30 $0.91B $6.74B 13.50%
2023-06-30 $0.90B $6.75B 14.19%
2023-03-31 $0.86B $6.71B 14.59%
2022-12-31 $0.81B $6.68B 14.81%
2022-09-30 $0.79B $5.18B 15.79%
2022-06-30 $0.78B $5.10B 16.03%
2022-03-31 $0.78B $4.91B 16.34%
2021-12-31 $0.52B $4.74B 11.14%
2021-09-30 $0.50B $4.73B 10.76%
2021-06-30 $0.48B $4.73B 10.27%
2021-03-31 $0.46B $4.59B 9.97%
2020-12-31 $0.70B $4.57B 15.29%
2020-09-30 $0.68B $4.62B 15.05%
2020-06-30 $0.62B $4.59B 14.13%
2020-03-31 $0.51B $4.51B 11.98%
2019-12-31 $0.46B $4.35B 10.89%
2019-09-30 $0.42B $4.16B 10.33%
2019-06-30 $0.41B $4.11B 10.70%
2019-03-31 $0.45B $4.10B 12.66%
2018-12-31 $0.45B $3.86B 13.34%
2018-09-30 $0.34B $3.07B 10.16%
2018-06-30 $0.32B $3.06B 9.26%
2018-03-31 $0.31B $3.53B 8.76%
2017-12-31 $0.29B $3.56B 8.20%
2017-09-30 $0.35B $3.49B 10.30%
2017-06-30 $0.34B $3.47B 10.14%
2017-03-31 $0.32B $3.42B 9.73%
2016-12-31 $0.33B $3.32B 10.59%
2016-09-30 $0.35B $3.32B 12.29%
2016-06-30 $0.35B $3.26B 13.85%
2016-03-31 $0.36B $2.45B 15.66%
2015-12-31 $0.36B $2.24B 15.95%
2015-09-30 $0.35B $2.26B 15.57%
2015-06-30 $0.35B $2.18B 15.48%
2015-03-31 $0.35B $2.28B 15.22%
2014-12-31 $0.35B $2.33B 15.04%
2014-09-30 $0.35B $2.31B 14.84%
2014-06-30 $0.35B $2.36B 14.71%
2014-03-31 $0.33B $2.37B 14.30%
2013-12-31 $0.33B $2.35B 14.07%
2013-09-30 $0.32B $2.34B 13.71%
2013-06-30 $0.31B $2.21B 13.40%
2013-03-31 $0.31B $2.38B 13.69%
2012-12-31 $0.29B $2.33B 13.16%
2012-09-30 $0.28B $2.25B 12.91%
2012-06-30 $0.26B $2.14B 12.42%
2012-03-31 $0.24B $2.13B 11.60%
2011-12-31 $0.23B $2.04B 11.24%
2011-09-30 $0.22B $1.94B 11.21%
2011-06-30 $0.23B $2.07B 11.73%
2011-03-31 $0.22B $1.96B 12.17%
2010-12-31 $0.22B $1.88B 12.37%
2010-09-30 $0.21B $1.79B 12.14%
2010-06-30 $0.19B $1.63B 11.55%
2010-03-31 $0.18B $1.71B 11.27%
2009-12-31 $0.17B $1.62B 11.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $37.259B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.711B 27.62
Boston Scientific (BSX) United States $154.351B 38.64
Stryker (SYK) United States $149.416B 31.24
EssilorLuxottica (ESLOY) France $132.057B 0.00
Medtronic (MDT) Ireland $115.083B 16.32
Lonza Group Ag (LZAGY) Switzerland $49.624B 0.00
Haleon (HLN) United Kingdom $44.474B 25.39
Agilent Technologies (A) United States $34.110B 22.24
GE HealthCare Technologies (GEHC) United States $34.090B 16.18
Terumo (TRUMY) Japan $24.459B 31.77
Koninklijke Philips (PHG) Netherlands $23.149B 16.24
Insulet (PODD) United States $20.550B 80.67
Zimmer Biomet Holdings (ZBH) United States $18.570B 11.93
Baxter (BAX) United States $14.641B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.157B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.825B 23.75
Lantheus Holdings (LNTH) United States $5.747B 14.50
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Perrigo (PRGO) Ireland $3.768B 9.55
Haemonetics (HAE) United States $3.683B 16.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.395B 28.21
ICU Medical (ICUI) United States $3.220B 23.75
QuidelOrtho (QDEL) United States $1.952B 13.42
LeMaitre Vascular (LMAT) United States $1.900B 42.47
AtriCure (ATRC) United States $1.550B 0.00
Acuren (TIC) United States $1.455B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 30.91
Phibro Animal Health (PAHC) United States $1.278B 16.34
AdaptHealth (AHCO) United States $1.237B 12.56
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.053B 0.00
InMode (INMD) Israel $0.932B 9.39
Kestra Medical Technologies (KMTS) United States $0.792B 0.00
Curaleaf Holdings (CURLF) Canada $0.749B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Tilray Brands (TLRY) Canada $0.661B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Evolus (EOLS) United States $0.613B 0.00
CeriBell (CBLL) United States $0.592B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.449B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.337B 0.00
VAREX IMAGING (VREX) United States $0.327B 12.02
Sanuwave Health (SNWV) United States $0.310B 0.00
Cresco Labs (CRLBF) United States $0.306B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.302B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Aurora Cannabis (ACB) Canada $0.257B 76.33
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.249B 11.30
Brainsway (BWAY) Israel $0.231B 61.17
Omeros (OMER) United States $0.230B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Verano Holdings (VRNOF) United States $0.226B 0.00
Biote (BTMD) United States $0.221B 6.22
Canopy Growth (CGC) Canada $0.215B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
High Tide (HITI) Canada $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.00
Vireo Growth (VREOF) United States $0.162B 0.00
Exagen (XGN) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.123B 15.13
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.101B 13.05
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.040B 54.00
Safety Shot (SHOT) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.87
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00